TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
Cell Reports Methods · 2023-04 · 3 (4) · 100459
DOI: 10.1016/j.crmeth.2023.100459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports Methods, 2023-04. Verfasst von Raphael Genolet und 17 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, Neoplasms. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Mats Paulsson Foundation, Biltema Foundation, Swiss National Science Foundation.
Abstract (Originalsprache)
T cell receptor (TCR) technologies, including repertoire analyses and T cell engineering, are increasingly important in the clinical management of cellular immunity in cancer, transplantation, and other immune diseases. However, sensitive and reliable methods for repertoire analyses and TCR cloning are still lacking. Here, we report on SEQTR, a high-throughput approach to analyze human and mouse repertoires that is more sensitive, reproducible, and accurate as compared with commonly used assays, and thus more reliably captures the complexity of blood and tumor TCR repertoires. We also present a TCR cloning strategy to specifically amplify TCRs from T cell populations. Positioned downstream of single-cell or bulk TCR sequencing, it allows time- and cost-effective discovery, cloning, screening, and engineering of tumor-specific TCRs. Together, these methods will accelerate TCR repertoire analyses in discovery, translational, and clinical settings and permit fast TCR engineering for cellular therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland.
- Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
Förderung
- Mats Paulsson Foundation
- Biltema Foundation
- Swiss National Science Foundation
- Fondation ISREC
Zitieren
APA
Genolet, R., Bobisse, S., Chiffelle, J., Arnaud, M., Petremand, R., Queiroz, L., Michel, A., Reichenbach, P., Cesbron, J., Auger, A., Baumgaertner, P., Guillaume, P., Schmidt, J., Irving, M., Kandalaft, L. E., Speiser, D. E., Coukos, G., & Harari, A. (2023). TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs. Cell Reports Methods, 3(4), 100459. https://doi.org/10.1016/j.crmeth.2023.100459
Vancouver
Genolet R, Bobisse S, Chiffelle J, Arnaud M, Petremand R, Queiroz L, et al. TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs. Cell Reports Methods. 2023;3(4):100459. doi:10.1016/j.crmeth.2023.100459
BibTeX
@article{Genolet2023,
author = {Genolet, Raphael and Bobisse, Sara and Chiffelle, Johanna and Arnaud, Marion and Petremand, Rémy and Queiroz, Lise and Michel, Alexandra and Reichenbach, Patrick and Cesbron, Julien and Auger, Aymeric and Baumgaertner, Petra and Guillaume, Philippe and Schmidt, Julien and Irving, Melita and Kandalaft, Lana E and Speiser, Daniel E and Coukos, George and Harari, Alexandre},
title = {TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs},
journal = {Cell Reports Methods},
year = {2023},
volume = {3},
number = {4},
pages = {100459},
doi = {10.1016/j.crmeth.2023.100459}
}
EUVIMED